Artia Global Partners LP Nuvalent, Inc. Transaction History
Artia Global Partners LP
- $280 Billion
- Q4 2024
A detailed history of Artia Global Partners LP transactions in Nuvalent, Inc. stock. As of the latest transaction made, Artia Global Partners LP holds 204,045 shares of NUVL stock, worth $14.3 Million. This represents 5.71% of its overall portfolio holdings.
Number of Shares
204,045
Previous 15,437
1221.79%
Holding current value
$14.3 Million
Previous $1.58 Billion
911.44%
% of portfolio
5.71%
Previous 0.43%
Shares
2 transactions
Others Institutions Holding NUVL
# of Institutions
232Shares Held
59MCall Options Held
834KPut Options Held
490K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.26 Billion34.87% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.36MShares$377 Million16.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$316 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$212 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.62MShares$184 Million6.84% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.02B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...